
- 300 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
About this book
This book provides detailed concepts and information on principles and processes of signal analysis in pharmacovigilance along with case studies. It covers the fundamental concepts and principles of pharmacovigilance, emphasizing the need for robust signal detection and analysis methods. The book reviews the diverse array of databases and tools employed for signal detection, including electronic health records (EHRs), social media mining, claims data, and distributed data networks. In turn, the book discusses the application of molecular dynamics, molecular docking, and the use of the FDA Adverse Event Reporting System (FAERS) database in signal analysis.
Toward the end, the book explores the identification, validation, and assessment of signals associated with vaccines. This book is useful for graduate, post-graduate students of pharmaceutical sciences, and scientists in pharmacology research and drug development.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover Page
- Half-Title Page
- Title Page
- Copyright Page
- Contents
- Editor
- Contributors
- Chapter 1 Introduction to Pharmacovigilance: Ensuring Patient Safety
- Chapter 2 Drug Safety Signal Detection and Management in Pharmacovigilance
- Chapter 3 Databases and Tools for Signal Detection of Drugs in Post-Marketing Surveillance
- Chapter 4 Role of Electronic Medical Records, Insurance Claims Data, Distributed Data Networks and Social Media in Signal Analysis
- Chapter 5 Uncovering False Alarms: Examining Biases and Confounders in Disproportionality Analysis
- Chapter 6 Role of Medical Coding in Signal Detection
- Chapter 7 Regulatory Aspects in Signal Detection and Assessment
- Chapter 8 Disproportionality Methods for Signal Detection in Pharmacovigilance
- Chapter 9 Bayesian Methods of Signal Detection
- Chapter 10 Subgroup and Sensitivity Analysis
- Chapter 11 Causality Assessment of ICSRs
- Chapter 12 Signal Analysis of Drug–Drug Interactions Using Spontaneous Reporting Method
- Chapter 13 Use of Network Pharmacological Approaches in Signal Analysis
- Chapter 14 Docking Studies in Signal Analysis: An Overview
- Chapter 15 Molecular Dynamics Simulations in Signal Validation
- Chapter 16 Identification and Validation of Novel Signals of Drugs Using the FAERS Database: A Case Study
- Chapter 17 Molecular Docking and Molecular Dynamics in Signal Analysis: A Case Study
- Chapter 18 Available Databases and Tools for Signal Detection of Vaccines
- Chapter 19 Identification and Validation of Signals Associated with Vaccines
- Chapter 20 Neurological and Behaviour Alterations with COVID-19 Vaccines Using the Vaccine Adverse Event Reporting System (VAERS): A Retrospective Study
- Chapter 21 Pharmacovigilance-Based Drug Repurposing via Inverse Signals
- Chapter 22 Prospective Role of Preclinical Experimentation in Validating Safety Signals
- Chapter 23 Role of Artificial Intelligence in Signal Detection
- Index